Literature DB >> 9696040

Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.

B H Lloyd1, A Platt-Higgins, P S Rudland, R Barraclough.   

Abstract

The rodent S100-related calcium-binding protein, S100A4 induces metastasis in non-metastatic rat and mouse benign mammary cells and co-operates with benign-tumour-inducing changes in two transgenic mouse models, to yield metastatic mammary tumours. Co-transfection of the human gene for S100A4 with pSV2neo into the benign rat mammary cell line, Rama 37, yielded cells which expressed a low level of the endogenous S100A4 mRNA, and either high or undetectable levels of human S100A4 mRNA. The cells which expressed a high level of human S100A4 mRNA induced metastasis in the benign rat mammary cell line Rama 37 in an in vivo assay, whereas the cells which expressed an undetectable level of human S100A4 did not induce any detectable metastases. The primary tumours arising from the S100A4-expressing cells contained high levels of immunocytochemically-detected S100A4 and this high level of S100A4 and the metastatic potential were maintained when cells from a metastasis were re-injected into syngeneic rats. The results show that the human S100A4 possesses metastasis-inducing capabilities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696040     DOI: 10.1038/sj.onc.1201948

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death.

Authors:  Eiichi Makino; Masakiyo Sakaguchi; Keiji Iwatsuki; Nam-ho Huh
Journal:  J Mol Med (Berl)       Date:  2004-07-06       Impact factor: 4.599

3.  S100A4 downregulates filopodia formation through increased dynamic instability.

Authors:  Connie Goh Then Sin; Nils Hersch; Philip S Rudland; Roger Barraclough; Bernd Hoffmann; Stephane R Gross
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

4.  Psoriasin (S100A7) expression and invasive breast cancer.

Authors:  S Al-Haddad; Z Zhang; E Leygue; L Snell; A Huang; Y Niu; T Hiller-Hitchcock; K Hole; L C Murphy; P H Watson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

6.  Crystal structure of metastasis-associated protein S100A4 in the active calcium-bound form.

Authors:  Puja Pathuri; Lutz Vogeley; Hartmut Luecke
Journal:  J Mol Biol       Date:  2008-05-07       Impact factor: 5.469

7.  Self-association of calcium-binding protein S100A4 and metastasis.

Authors:  Thamir M Ismail; Shu Zhang; David G Fernig; Stephane Gross; Marisa L Martin-Fernandez; Violaine See; Kaeko Tozawa; Christopher J Tynan; Guozheng Wang; Mark C Wilkinson; Philip S Rudland; Roger Barraclough
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

8.  S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.

Authors:  Kin-Hoe Chow; Hee Jung Park; Joshy George; Keiko Yamamoto; Andrew D Gallup; Joel H Graber; Yuanxin Chen; Wen Jiang; Dennis A Steindler; Eric G Neilson; Betty Y S Kim; Kyuson Yun
Journal:  Cancer Res       Date:  2017-08-14       Impact factor: 12.701

9.  Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression.

Authors:  S R Grey; S S Dlay; B E Leone; F Cajone; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.

Authors:  Nuria Mencía; Elisabet Selga; Isabel Rico; M Cristina de Almagro; Xenia Villalobos; Sara Ramirez; Jaume Adan; Jose L Hernández; Véronique Noé; Carlos J Ciudad
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.